Literature DB >> 4073667

Dynamic aspects of the in vitro chemotherapeutic activity of ansamycin (rifabutine) on mycobacterium intracellulare.

V K Perumal, P R Gangadharam, L B Heifets, M D Iseman.   

Abstract

The in vitro action of ansamycin against Mycobacterium intracellulare was studied using continuous, dynamic (a rapidly falling off concentration simulating that existing in vivo in humans), and pulsed exposures. Ansamycin at a concentration of 5 micrograms/ml showed bactericidal activity starting from as early as 3 days after constant exposure. In the dynamic model with the drug present in bactericidal concentration for only 2 h a day, bactericidal activity was demonstrated. With pulsed exposure, a minimal period of 72 to 96 h is necessary for effective inhibitory action.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4073667     DOI: 10.1164/arrd.1985.132.6.1278

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

1.  Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents.

Authors:  D M Yajko; P S Nassos; W K Hadley
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

2.  Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages.

Authors:  C Perronne; A Gikas; C Truffot-Pernot; J Grosset; J J Pocidalo; J L Vilde
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

3.  Activity of amikacin against Mycobacterium avium complex under simulated in vivo conditions.

Authors:  P R Gangadharam; L Kesavalu; P N Rao; V K Perumal; M D Iseman
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

Review 4.  Clinical pharmacokinetics of rifabutin.

Authors:  M H Skinner; T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

Review 5.  Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; A Fitton
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.